BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 27218427)

  • 1. A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules.
    Daina A; Zoete V
    ChemMedChem; 2016 Jun; 11(11):1117-21. PubMed ID: 27218427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors.
    Yousuf M
    Curr Cancer Drug Targets; 2019; 19(11):906-918. PubMed ID: 30894110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model.
    Paixão P; Gouveia LF; Morais JA
    Int J Pharm; 2012 Jun; 429(1-2):84-98. PubMed ID: 22449410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug dissolution: significance of physicochemical properties and physiological conditions.
    Jambhekar SS; Breen PJ
    Drug Discov Today; 2013 Dec; 18(23-24):1173-84. PubMed ID: 24042023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating the Impact of Lipophilicity on Potency and Pharmacokinetic Parameters Enables the Use of Diverse Chemical Space during Small Molecule Drug Optimization.
    Miller RR; Madeira M; Wood HB; Geissler WM; Raab CE; Martin IJ
    J Med Chem; 2020 Nov; 63(21):12156-12170. PubMed ID: 32633947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds.
    Tubic-Grozdanis M; Bolger MB; Langguth P
    AAPS J; 2008; 10(1):213-26. PubMed ID: 18446522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept.
    Reichel A
    Chem Biodivers; 2009 Nov; 6(11):2030-49. PubMed ID: 19937839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building predictive ADMET models for early decisions in drug discovery.
    Penzotti JE; Landrum GA; Putta S
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):49-61. PubMed ID: 14982148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational approaches towards the rational design of drug-like compound libraries.
    Matter H; Baringhaus KH; Naumann T; Klabunde T; Pirard B
    Comb Chem High Throughput Screen; 2001 Sep; 4(6):453-75. PubMed ID: 11562252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.
    Daina A; Michielin O; Zoete V
    Sci Rep; 2017 Mar; 7():42717. PubMed ID: 28256516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Prediction for Intestinal Absorption and Brain Penetration of Chemical Pesticides in Humans.
    Chedik L; Mias-Lucquin D; Bruyere A; Fardel O
    Int J Environ Res Public Health; 2017 Jun; 14(7):. PubMed ID: 28665355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologically active metabolites in drug discovery.
    Sun S; Wesolowski SS
    Bioorg Med Chem Lett; 2021 Sep; 48():128255. PubMed ID: 34245850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collision cross sections obtained with ion mobility mass spectrometry as new descriptor to predict blood-brain barrier permeation by drugs.
    Guntner AS; Thalhamer B; Klampfl C; Buchberger W
    Sci Rep; 2019 Dec; 9(1):19182. PubMed ID: 31844124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical profiling (solubility, permeability and charge state).
    Avdeef A
    Curr Top Med Chem; 2001 Sep; 1(4):277-351. PubMed ID: 11899112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bioavailability of oral drug formulations and methods for its improvement].
    Ipatova OM; Torkhovskaia TI; Medvedeva NV; Prozorovskiĭ VN; Ivanova ND; Shironin AV; Baranova VS; Archakov AI
    Biomed Khim; 2010; 56(1):101-19. PubMed ID: 21328915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive approaches to increase absorption of compounds during lead optimisation.
    Valko K; Butler J; Eddershaw P
    Expert Opin Drug Discov; 2013 Oct; 8(10):1225-38. PubMed ID: 23865945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep learning approaches in predicting ADMET properties.
    Cáceres EL; Tudor M; Cheng AC
    Future Med Chem; 2020 Nov; 12(22):1995-1999. PubMed ID: 33124448
    [No Abstract]   [Full Text] [Related]  

  • 20. Theoretical predictions of drug absorption in drug discovery and development.
    Stenberg P; Bergström CA; Luthman K; Artursson P
    Clin Pharmacokinet; 2002; 41(11):877-99. PubMed ID: 12190333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.